Vitamin D intake from foods and supplements and depressive symptoms in a diverse population of older women

American Journal of Clinical Nutrition

Volumn 94, Issue 4, 2011, Pages 1104-1112

  Bertone Johnson, Elizabeth R ^a   Powers, Sally I ^a   Spangler, Leslie ^b   Brunner, Robert L ^c   Michael, Yvonne L ^d   Larson, Joseph C ^e   Millen, Amy E ^f   Bueche, Maria N ^g   Salmoirago Blotcher, Elena ^h   Liu, Simin ⁱ   Wassertheil Smoller, Sylvia ^j   Ockene, Judith K ^h   Ockene, Ira ^h   Manson, JoAnn E ^g  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b GROUP HEALTH RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^d DREXEL UNIVERSITY   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f UNIVERSITY AT BUFFALO   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VITAMIN D;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEPRESSION; DIET SUPPLEMENTATION; FEMALE; FOOD COMPOSITION; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PHYSICAL ACTIVITY; POSTMENOPAUSE; PREVALENCE; PROSPECTIVE STUDY; SECONDARY ANALYSIS; VITAMIN INTAKE;

AGED; ANTIDEPRESSIVE AGENTS; CROSS-SECTIONAL STUDIES; DEPRESSION; DIET; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PREVALENCE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; RISK; UNITED STATES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 80053205532     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.017384     Document Type: Article

References (46)

1. Bertone-Johnson ER. Vitamin D and the occurrence of depression: causal association or circumstantial evidence? Nutr Rev 2009;67:481-92.
2. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002;13:100-5. (Pubitemid 36733998)
3. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 2005;29:21-30. (Pubitemid 39602785)
4. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, Hewison M. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001;86:888-94. (Pubitemid 32207511)
5. McGrath JJ, Feron FP, Burne TH, Mackay-Sim A, Eyles DW. Vitamin D3-implications for brain development. J Steroid Biochem Mol Biol 2004;89-90:557-60.
6. Mora JR, Iwata M, Von Andriano UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008;8: 685-98.
7. van Etten E, Stoffels K, Gysemans C, Mathieu C, Overbergh L. Regulation of vitamin D homeostasis: implications for the immune system. Nutr Rev 2008;66:S125-34.
8. Nemerovski CW, Dorsch MP, Simpson RU, Bone HG, Aaronson KD, Bleske BE. Vitamin D and cardiovascular disease. Pharmacotherapy 2009;29:691-708.
9. Pan A, Lu L, Franco OH, Yu Z, Li H, Lin X. Association between depressive symptoms and 25-hydroxyvitamin D in middle-aged and elderly Chinese. J Affect Disord 2009;118:240-3.
10. Nanri A, Mizoue T, Matsushita Y, Poudel-Tandukar K, Sato M, Ohta M, Mishima N. Association between serum 25-hydroxyvitamin D and depressive symptoms in Japanese: analysis by survey season. Eur J Clin Nutr 2009;63:1444-7.
11. Stewart R, Hirani V. Relationship between vitamin D levels and depressive symptoms in older residents from a national survey population. Psychosom Med 2010;72:608-12.
12. Jorde R, Waterloo K, Saleh F, Haug E, Svartberg J. Neuropsychological function in relation to serum parathyroid hormone and serum 25- hydroxyvitamin D levels. The Tromso study. J Neurol 2006;253:464-70. (Pubitemid 43965611)
13. Hoogendijk WJ, Lips P, Dik MG, Deeg DJ, Beekman AT, Penninx BW. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry 2008;65:508-12. (Pubitemid 351645046)
14. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 2006;14:1032-40. (Pubitemid 44936995)
15. Schneider B, Weber B, Frensch A, Stein J, Fritz J. Vitamin D in schizophrenia, major depression and alcoholism. J Neural Transm 2000;107:839-42. (Pubitemid 30468270)
16. Zhao G, Ford ES, Li C, Balluz LS. No associations between serum concentrations of 25-hydroxyvitamin D and parathyroid hormone and depression among US adults. Br J Nutr 2010;104:1696-702.
17. Ganji V, Milone C, Cody MM, McCarty F, Wang YT. Serum vitamin D concentrations are related to depression in young adult US population: the Third National Health and Nutrition Examination Survey. Int Arch Med 2010;3:29.
18. May HT, Bair TL, Lappe DL, Anderson JL, Horne BD, Carlquist JF, Muhlestein JB. Association of vitamin D levels with incident depression among a general cardiovascular population. Am Heart J 2010; 159:1037-43.
19. Milaneschi Y, Shardell M, Corsi AM, Vazzana R, Bandinelli S, Guralnik JM, Ferrucci L. Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. J Clin Endocrinol Metab 2010;95:3225-33
20. Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterloo K. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med 2008; 264:599-609.
21. Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M. The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 2003;13:S107-21. (Pubitemid 37324180)
22. Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs- Collins T. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol 1999;9:178-87. (Pubitemid 29144458)
23. Patterson RE, Levy L, Tinker LF, Kristal AR. Evaluation of a simplified vitamin supplement inventory developed for the Women's Health Initiative. Public Health Nutr 1999;2:273-6. (Pubitemid 29446589)
24. Patterson RE, Kristal AR, Levy L, McLerran D, White E. Validity of methods used to assess vitamin and mineral supplement use. Am J Epidemiol 1998;148:643-9. (Pubitemid 28498431)
25. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ 1993;2:217-27.
26. Beasley JM, LaCroix AZ, Neuhouser ML, Huang Y, Tinker L, Woods N, Michael Y, Curb JD, Prentice RL. Protein intake and incident frailty in the Women's Health Initiative observational study. J Am Geriatr Soc 2010;58:1063-71.
27. Millen AE, Pettinger M, Freudenheim JL, et al. Incident invasive breast cancer, geographic location of residence, and reported average time spent outside. Cancer Epidemiol Biomarkers Prev 2009;18:495-507.
28. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 1980;9:227-31. (Pubitemid 11238851)
29. Burnam MA, Wells KB, Leake B, Landsverk J. Development of a brief screening instrument for detecting depressive disorders. Med Care 1988;26:775-89.
30. Tuunainen A, Langer RD, Klauber MR, Kripke DF. Short version of the CES-D (Burnam screen) for depression in reference to the structured psychiatric interview. Psychiatry Res 2001;103:261-70. (Pubitemid 32817085)
31. Kim CK, McGorray SP, Bartholomew BA, et al. Depressive symptoms and heart rate variability in postmenopausal women. Arch Intern Med 2005;165:1239-44. (Pubitemid 40989587)
32. Spangler L, Scholes D, Brunner RL, Robbins J, Reed SD, Newton KM, Melville JL, Lacroix AZ. Depressive symptoms, bone loss, and fractures in postmenopausal women. J Gen Intern Med 2008;23:567-74.
33. Wassertheil-Smoller S, Shumaker S, Ockene J, Talavera GA, Greenland P, Cochrane B, Robbins J, Aragaki A, Dunbar-Jacob J. Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI). Arch Intern Med 2004;164:289-98. (Pubitemid 38176467)
34. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes: calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: National Academies Press, 1997.
35. Chlebowski RT, Johnson KC, Kooperberg C, et al. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 2008;100:1581-91.
36. Fugh-Berman A, Cott JM. Dietary supplements and natural products as psychotherapeutic agents. Psychosom Med 1999;61:712-28. (Pubitemid 29455091)
37. Appleton KM, Rogers PJ, Ness AR. Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr 2010;91:757-70.
38. Lin J, Manson JE, Lee IM, Cook NR, Buring JE, Zhang SM. Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med 2007;167:1050-9. (Pubitemid 46835793)
39. Shin MH, Holmes MD, Hankinson SE, Wu K, Colditz GA, Willett WC. Intake of dairy products, calcium, and vitamin d and risk of breast cancer. J Natl Cancer Inst 2002;94:1301-11.
40. McCullough ML, Rodriguez C, Diver WR, Feigelson HS, Stevens VL, Thun MJ, Calle EE. Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 2005;14:2898-904. (Pubitemid 43068822)
41. Millen AE, Wactawski-Wende J, Pettinger M, Melamed ML, Tylavsky FA, Liu S, Robbins J, LaCroix AZ, LeBoff MS, Jackson RD. Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: theWomen's Health Initiative Calcium plus Vitamin D clinical trial. Am J Clin Nutr 2010;91:1324-35.
42. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academies Press, 2010.
43. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006;98: 451-9.
44. Pizzi C, Mancini S, Angeloni L, Fontana F, Manzoli L, Costa GM. Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease. Clin Pharmacol Ther 2009;86:527-32.
45. Kenis G, Maes M. Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol 2002;5:401-12. (Pubitemid 35470359)
46. Holick MF. Vitamin D: a D-Lightful health perspective. Nutr Rev 2008;66:S182-94.